versión imprimible

2nd Gene Therapy Immunogenicity

Evvnt Promotion / evvnt
03.08.2021 - 05.08.2021  Online
Time: 08:00 - 17:30
Temas de la conferencia
The 2nd Gene Therapy Immunogenicity Summit is the industry's definitive forum enabling you to better modulate, measure and predict immune response to your gene therapy candidate.

In the context of ever-increasing gene therapy clinical activity and uncertainty around immunogenicity challenges, the Gene Therapy Immunogenicity Summit will unite large pharma and innovative biotechs to ensure that you're up to speed on the latest approaches to predict, measure
Organizador profesional (PCO)
Hanson Wade
Speakers: Andrew Byrnes, Head Gene Transfer and Immunogenicity Branch, FDA, Klaudia Kuranda, Immunology Lead, Spark Therapeutics, David Markusic, Research Professor, IUPUI, Cathryn Clary, Acting Chief Medical Officer, Bridge Bio and more.

Información e inscripción:
Ms. Ellie Saunders
Medicina General
Cuota del Congreso
Conference Only Ticket (First Release): $1599.0, Conference Only Ticket (Second Release): $1699.0, Conference Only Ticket (Third Release): $1899.0, Conference Only Ticket (Fourth Release): $1999.0, Conference Only Ticket (Final Price): $2099.0
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Hilfswerk AustriaHelix - Forschung & Beratung WienCenter of ExcellenceÄrzte der WeltEuropean Public Health Association (EUPHA)Alumni Club Medizinische Universität WienAGEM - Arbeitsgemeinschaft Ethnologie und MedizinAnästhesie in Entwicklungsländern e. V.